Dishman Biotech Profile
Key Indicators
- Authorised Capital ₹ 6.50 Cr
- Paid Up Capital ₹ 6.50 Cr
- Company Age 29 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 157.46 Cr
- Satisfied Charges ₹ 8.95 Cr
- Revenue Growth 4.32%
- Profit Growth -40.44%
- Ebitda 92.20%
- Net Worth 9.51%
- Total Assets 36.86%
About Dishman Biotech
Dishman Biotech Limited (DBL) is a leading Public Limited Indian Non-Government Company incorporated in India on 08 November 1995 and has a history of 29 years and three months. Its registered office is in Ahmedabad, Gujarat, India.
The Corporate was formerly known as Schutz Dishman Biotech Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.50 Cr and a paid-up capital of Rs 6.50 Cr.
The company currently has active open charges totaling ₹157.46 Cr. The company has closed loans amounting to ₹8.95 Cr, as per Ministry of Corporate Affairs (MCA) records.
Janmejay Vyas, Deohooti Vyas, Aditi Vyas, and One other member serve as directors at the Company.
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24231GJ1995PLC028060
- Company No.
028060
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
08 Nov 1995
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Dishman Biotech?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aditi Vyas  | Director | 01-Dec-1997 | Current |
| Janmejay Vyas | Director | 08-Nov-1995 | Current |
| Deohooti Vyas | Director | 01-Dec-1997 | Current |
| Arpit Vyas | Director | 03-Jun-2009 | Current |
Financial Performance of Dishman Biotech.
Dishman Biotech Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 4.32% increase. The company also saw a substantial fall in profitability, with a 40.44% decrease in profit. The company's net worth moved up by a moderate rise of 9.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dishman Biotech?
In 2023, Dishman Biotech had a promoter holding of 99.99%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Dishman Carbogen Amcis LimitedJanmejay Vyas, Deohooti Vyas and 1 more are mutual person
Azafran Innovacion LimitedDeohooti Vyas and Aditi Vyas are mutual person
Adimans Technologies LlpJanmejay Vyas and Arpit Vyas are mutual person
- B R Laboratories Limited
Janmejay Vyas, Deohooti Vyas and 1 more are mutual person
- Dishman Infrastructure Limited
Janmejay Vyas and Aditi Vyas are mutual person
- Rtv Technochem Private Limited
Janmejay Vyas and Deohooti Vyas are mutual person
Charges (Loans)
₹157.46 Cr
₹8.95 Cr
Charges Breakdown by Lending Institutions
- Others : 157.46 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Apr 2024 | Others | ₹38.00 Cr | Open |
| 18 Feb 2020 | Others | ₹40.73 Cr | Open |
| 18 Feb 2020 | Others | ₹45.00 Cr | Open |
| 18 Feb 2020 | Others | ₹33.73 Cr | Open |
| 04 Jun 2002 | Corporation Bank | ₹4.00 Cr | Satisfied |
How Many Employees Work at Dishman Biotech?
Dishman Biotech has a workforce of 17 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dishman Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dishman Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
